Cui · Cell 2007 · Laboratory biochemical, genetic, and knockout animal study · n=?

Central role of p53 in the suntan response and pathologic hyperpigmentation.

Cited 644 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Bench and knockout animal research without clinical data

PubMed 17350573 · doi:10.1016/j.cell.2006.12.045 · record verified 2026-08-27

What was done

The authors used biochemical and genetic assays to evaluate the role of p53 in ultraviolet (UV)-induced pro-opiomelanocortin (POMC) and alpha-melanocyte-stimulating hormone (alpha-MSH) induction in skin. They examined p53 stimulation of the POMC promoter, tested the UV-tanning response in p53 knockout mice, and evaluated p53 involvement in UV-independent pathologic hyperpigmentation.

What was found

p53 was shown to directly control UV induction of POMC and alpha-MSH by stimulating the POMC promoter. p53 knockout mice showed an absence of the UV-tanning response. The pathway was also found to produce the POMC derivative beta-endorphin and to be active in several forms of UV-independent pathologic pigmentation. No quantitative data, sample sizes, or effect sizes were reported in the abstract.

Why it matters

This work identifies tumor suppressor p53 as the direct molecular sensor and transcriptional regulator controlling the tanning response to UV light, linking DNA damage signaling to skin pigmentation and endorphin production.

Limits

The abstract reports only preclinical molecular assays and mouse models, without human clinical data or sample sizes. Hypotheses regarding beta-endorphin contributing to sun-seeking behaviors remain speculative without behavioral quantification in humans. No numerical metrics or statistical bounds are provided in the abstract.

Cited by